Efficacy Study of T2 Versus AZA to Maintain Clinical and Endoscopic Remission in Postoperative Crohn's Disease
Status:
Unknown status
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see whether T2 versus Azathioprine is able to maintain the
clinical and endoscopic remission in subjects with Crohn's disease after surgery-induced
remission.
The side effects related to T2 and AZA will also be monitored throughout the study.